Hematology & Oncology Doctors in Ridley Park, PA Accepting Medicare

5 Hematology & Oncology doctors found. Showing 1 - 5

Andrew J Solan, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 33 W Chester Pike, Ridley Park, PA 19078 Phone: 610-521-2012    Fax: 610-521-3753

Rashmi Sanjay, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 33 W Chester Pike, Ridley Park, PA 19078 Phone: 610-521-2012    Fax: 610-521-3753

Melvyn J Lapes, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 33 W Chester Pike, Ridley Park, PA 19078 Phone: 610-521-2012    Fax: 610-521-3753

Lee H Bogart, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 33 W Chester Pike, Ridley Park, PA 19078 Phone: 610-521-2012    Fax: 610-521-3753

Brian S Wojciechowski, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 33 W Chester Pike, Ridley Park, PA 19078 Phone: 610-521-2010    Fax: 610-521-3753

News Archive

BrainStorm's phase 2a ALS study meets primary endpoint

BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced positive final results from its phase 2a clinical trial of NurOwn™ in amyotrophic lateral sclerosis (ALS) patients, which enrolled 14 subjects at Hadassah Medical Center in Jerusalem.

Home-based telehealth therapy program effective for stroke rehabilitation, shows study

In-home rehabilitation, using a telehealth system and supervised by licensed occupational/physical therapists, is an effective means of improving arm motor status in stroke survivors, according to findings presented by University of California, Irvine neurologist Steven C. Cramer, MD, at the recent 2018 European Stroke Organisation Conference in Gothenburg, Sweden.

New test for breast cancer metastasis

Scientists at Albert Einstein College of Medicine of Yeshiva University have previously shown that the co-mingling of three cell types can predict whether localized breast cancer will spread throughout the body.

Rare genetic variants have a big impact on the risk of developing type 2 diabetes

Scientists at the University of Cambridge have identified rare genetic variants - carried by one in 3,000 people - that have a larger impact on the risk of developing type 2 diabetes than any previously identified genetic effect.

Researchers develop ingestible sensor to non-invasively monitor indicators of disease

NIBIB-funded researchers at the Massachusetts Institute of Technology have created an ingestible sensor to non-invasively monitor indicators of disease in the stomach and intestines.

Read more Medical News

› Verified 6 days ago